Abstract:Background: In recent years, observational studies have provided evidence supporting a potential association between autism spectrum disorder (ASD) and gut microbiota. However, the causal effect of gut microbiota on ASD remains unknown. Methods: We identified the summary statistics of 206 gut microbiota from the MiBioGen study, and ASD data were obtained from the latest Psychiatric Genomics Consortium Genome-Wide Association Study (GWAS). We then performed Mendelian randomization (MR) to determine a causal relationship between the gut microbiota and ASD using the inverse variance weighted (IVW) method, simple mode, MR-Egger, weighted median, and weighted model. Furthermore, we used Cochran's Q test, MR-Egger intercept test, Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), and leave-one-out analysis to identify heterogeneity and pleiotropy. Moreover, the Benjamin-Hochberg approach (FDR) was employed to assess the strength of the connection between exposure and outcome. We performed reverse MR analysis on the gut microbiota that were found to be causally associated with ASD in the forward MR analysis to examine the causal relationships. The enrichment analyses were used to analyze the biological function at last. Results: Based on the results of IVW results, genetically predicted family Prevotellaceae and genus Turicibacter had a possible positive association with ASD (IVW OR=1.14, 95% CI: 1.00-1.29, P =3.7×10 −2 ), four gut microbiota with a potential protective effect on ASD: genus Dorea (OR=0.81, 95% CI: 0.69-0.96, P =1.4×10 −2 ), genus Ruminiclostridium5 (OR=0.81, 95% CI: 0.69-0.96, P =1.5×10 −2 ), genus Ruminococcus1 (OR=0.83, 95% CI: 0.70-0.98, P =2.8×10 −2 ), and genus Sutterella (OR=0.82, 95% CI: 0.68-0.99, P =3.6×10 −2 ). After FDR multiple-testing correction we further observed that there were two gut microbiota still have significant relationship with ASD: family Prevotellaceae (IVW OR=1.24; 95% CI: 1.09-1.40, P =9.2×10 -4 ) was strongly positively correlated with ASD and genus RuminococcaceaeUCG005 (IVW OR=0.78, 95% CI: 0.67-0.89, P =6.9×10 −4 ) was strongly negatively correlated with ASD. The sensitivity analysis excluded the influence of heterogeneity and horizontal pleiotropy. Conclusion: Our findings reveal a causal association between several gut microbiomes and ASD. These results deepen our comprehension of the role of gut microbiota in ASD's pathology, providing the foothold for novel ideas and theoretical frameworks to prevent and treat this patient population in the future.

microRNAs and Gene–Environment Interactions in Autism: Effects of Prenatal Maternal Stress and the SERT Gene on Maternal microRNA Expression

Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development

Maternal serotonin transporter genotype affects risk for ASD with exposure to prenatal stress.

Behavioral and Molecular Characterization of Prenatal Stress Effects on the C57BL/6J Genetic Background for the Study of Autism Spectrum Disorder

Alterations in the MicroRNA of the Blood of Autism Spectrum Disorder Patients: Effects on Epigenetic Regulation and Potential Biomarkers

Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles

The early life exposome and autism risk: a role for the maternal microbiome?

Autism Spectrum Disorder: A Neuro-Immunometabolic Hypothesis of the Developmental Origins

Associations of endocrine stress-related gene polymorphisms with risk of autism spectrum disorders: Evidence from an integrated meta-analysis.

Perinatal stress, brain inflammation and risk of autism-Review and proposal

MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research

Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia

Gut microbiota and autism spectrum disorders: a bidirectional Mendelian randomization study

Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental Roles via regulating Mitochondria, Exosomes, Immunity and microRNAs

Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota

Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms

Absence of association between maternal adverse events and long-term gut microbiome outcomes in the Australian autism biobank

A heritable profile of six miRNAs in autistic patients and mouse models

Dysregulation of the mTOR-FMRP pathway and synaptic plasticity in an environmental model of ASD

Investigation of Gene Regulatory Networks Associated with Autism Spectrum Disorder Based on MiRNA Expression in China

Untargeted Metabolomics Screen of Mid-pregnancy Maternal Serum and Autism in Offspring